Oramed Submits Protocol To US FDA For Phase11B Oral Insulin
May 26, 2015 at 08:17 AM EDT
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) ( http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the development ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.